Sun.Dec 31, 2023

article thumbnail

Drug Patent Expirations for the Week of December 31, 2023

Drug Patent Watch

TASIGNA (nilotinib hydrochloride) Novartis Patent: 7,169,791 Expiration: Jan 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or… The post Drug Patent Expirations for the Week of December 31, 2023 appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

The Non Invasive Frontier: Liquid Biopsy Companies Refining Healthcare

Roots Analysis

Cancer has high mortality rate, primarily because of the delayed detection and complexities of current diagnostic procedures. The mortality rates associated with cancer can be significantly reduced if the efforts shift towards the development of methods for early detection of cancer. Amid the increasing burden of cancer and the limitations of traditional tissue biopsies, there is an evident surge in the demand for safe, non-invasive, and versatile diagnostic options.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New patent expiration for Novartis drug LEQVIO

Drug Patent Watch

Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seventeen patents protecting… The post New patent expiration for Novartis drug LEQVIO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

New patent expiration for Alnylam Pharms drug GIVLAARI

Drug Patent Watch

Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one NDA. It is available from one supplier. There are thirteen… The post New patent expiration for Alnylam Pharms drug GIVLAARI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Which pharmaceutical companies have the most drug patents in South Africa?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in South Africa. Patents must be filed in each country (or, in some cases regional patent office) where patent protection… The post Which pharmaceutical companies have the most drug patents in South Africa? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 45